Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-10

Clinical Trial Update: 2-HOBA in Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of 2-HOBA for systemic lupus erythematosus is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 2-HOBA (2-HOBA (2-hydroxybenzylamine))

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Systemic Lupus Erthematosus (SLE) | Phase 2 | Status: NOT_YET_RECRUITING